May 24, 2021Open Access
Myocarditis and inflammatory cardiomyopathy in 2021 – an update
Key Result
Endomyocardial biopsy remains the diagnostic gold standard for myocarditis and is essential for guiding etiology-directed immunosuppressive or antiviral therapies.
PICO
P
Population
Myocarditis and inflammatory cardiomyopathy
Limitations
- High-quality and systematic data for myocarditis treatment are absent
- Most available studies are small or report very heterogenous groups without clear diagnostic and etiologic definitions
Abstract
DOI: 10.20452/pamw.16010, Published online: May 24, 2021, Authors: Agata Tymińska1, Krzysztof Ozierański1, Alida L. P. Caforio2, Renzo Marcolongo2,3, Michał Marchel1, Agnieszka Kapłon-Cieślicka1, Anna Baritussio2, Krzysztof J. Filipiak1, Grzegorz Opolski1, Marcin Grabowski1